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Recent advances in stem cell biology have established the 
feasibility of reprogramming human and murine ﬁ  bro-
blast cells into induced pluripotent stem (iPS) cells [1-3]. 
Th  e ectopic expression of four transcription factors 
(Oct4, Sox2, c-Myc, and Klf4) in ﬁ  broblasts was shown to 
be eﬃ   cacious in the conversion of ﬁ  broblast cells into 
embryonic stem (ES) cell-like status. Generation of iPS 
cells ushers in a new era in reprogramming diﬀ  erentiated 
somatic cells, including ﬁ   broblasts, neural cells, liver 
cells, stomach cells, and blood cells, into ES cell-like stem 
cells [4]. With the progress of iPS technology, the concept 
of ‘master regulators’, deﬁ  ned as a group of major repro-
gramming factors playing a critical role in the manage-
ment of cell status of ‘pluripotent’ versus ‘diﬀ  erentiated’, 
has been demonstrated. Th   e group of master regulators 
for iPS cell generation is found to be eﬀ  ective with only 
three genes [5], which is far fewer than the hundreds or 
thousands of genes that were presumed to be involved in 
the determination of cell fate or status.
Successful reprogramming of ﬁ  broblast cells into iPS 
cells raised the possibility of directly converting one 
somatic cell type into other cell types. By overexpressing 
Ngn3, Pdx1, and Mafa, Zhou and colleagues [6] reported 
the conversion of exocrine pancreas cells into cells closely 
resembling beta cells and having the function of secreting 
insulin. In 2010, successful reprogramming of ﬁ  broblast 
cells into functional neuron cells was reported with the 
enforced expression of Ascl1, Brn2, and Myt1l [7]. 
Recently, Srivastava’s group [8] used the same strategy 
and reported another breakthrough in direct reprogram-
ming of mouse ﬁ  broblast cells into beating cardiomyocyte-
like cells: the transduction of a set of three cardiac master 
factors important in early heart development (Gata4, 
Mef2c, and Tbx5). Th  is is the ﬁ  rst paper to reveal the 
possibility of directly committing ﬁ   broblast cells into 
heart muscle cells that exhibit electrophysiological 
characteristics similar to those of adult cardiomyocytes. 
By comparing the transcription proﬁ  le of mouse cardio-
myocytes with that of cardiac ﬁ  broblasts, Srivastava and 
colleagues [8] selected 14 key cardiac speciﬁ  c trans  crip-
tional factors as the starting pool. In addition, the authors 
isolated the Th  y1+/αMHC-GFP− ﬁ  broblast cells from the 
neonatal mouse heart. Th  e 14 factors were introduced 
into Th  y1+/αMHC-GFP− cardiac ﬁ   broblast cells with 
retro-virus, and αMHC-GFP+  cells were shown after 
1 week of transduction, indicating the cardiac potential 
of reprogrammed ﬁ   broblast cells. Of the 14 factors, 
Gata4, Mef2c, and Tbx5 were identiﬁ  ed as being suﬃ   -
cient for cardiomyocyte reprogramming and having the 
capability of generating 20% αMHC-GFP+- and 6.5% 
cTNT+-induced cardiomyocytes (iCMs). Th   e iCMs show 
a clear sarcomeric organization and a global gene expres-
sion pattern similar to those of postnatal mouse 
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© 2011 BioMed Central Ltdcardio myo cytes.  Th   e iCMs also gain an epigenetic status 
similar to that of cardiomyocytes, indicating that the 
ﬁ  broblasts were epigenetically converted to cardiomyocyte-
like cells.
Considering the possibility that iCMs could be derived 
from the subtle heart progenitor cells existing within the 
Th  y1+/αMHC-GFP− cardiac ﬁ  broblast cells, Srivastava’s 
group induced iCMs from mouse tail dermal ﬁ  broblast 
cells as well as from the Th  y1+/αMHC-GFP−/c-kit−, Isl1-
YFP/Th  y1+, and Mesp1-YFP−/Th  y1+ ﬁ  broblast cells. c-kit, 
Isl1, and Mesap1 have been used as markers of the 
cardiac progenitor cells and the early mesodermal cells 
before cardiac commitment. Direct reprogramming of 
iCMs from the above ﬁ  broblast cells strongly supported 
the view that iCMs originated from diﬀ  erentiated ﬁ  bro-
blast cells, not from a subpopulation of heart progenitors. 
Most interestingly, the iCMs exhibit electrophysiological 
characteristics resembling those of adult ventricular 
cardiomyocytes. As human ES cell- and iPS cell-derived 
cardiomyocytes show phenotypes of fetal cardiomyocytes 
[9,10], the adult cardiomyocyte-like characteristics of 
iCMs could provide more clues in understanding how to 
induce ES cell- and iPS cell-derived cardiomyocytes into 
a mature status.
Th   is paper paved the way for the generation of a large 
number of cardiomyocyte-like cells and has important 
implications in understanding heart developmental 
biology as well as in the potential therapies of human 
cardiovascular diseases. For example, global knockouts of 
key cardiac transcriptional factors, such as Isl1 [11], 
exhibit embryonic lethality. Whether iCMs could be 
induced from ﬁ   broblast cells of the global knockout 
embryos and whether the eﬃ   ciency of iCMs could be 
aﬀ   ected by the knockout genes are very interesting 
questions in the ﬁ   eld of developmental biology. Th  is 
paper [8] also reported that cardiac ﬁ  broblast cells can 
give rise to a much higher frequency of iCMs than the tail 
ﬁ   broblast cells can. Determining whether the ‘tissue 
memory’ aﬀ   ects the reprogramming and elucidating 
what the mechanism is would also be interesting 
questions. Th   e future genera  tion of iCMs from humans, 
especially from patients with genetically caused 
cardiovascular diseases, would provide a unique system 
in which to understand those inherited diseases. 
However, there are still some issues to be addressed in 
the direct reprogramming of iCMs. Th  e ﬁ   rst is how 
closely the iCMs can resemble the electro  physiological 
characteristics of adult cardiomyocytes. Activation of the 
Ca2+ channel in iCMs was reported. How about the 
activities of K+ and Na+ channels in iCMs? Second, this 
paper reported the induction of approxi  mately 25% of 
αMHC-GFP+ cells, and only 5% to 6% of cTNT+ 
cardiomyocytes after the direct repro  gram  ming. Future 
studies need to improve the repro  gramming eﬃ   ciency. 
Th  e third is whether ectopic expression of the three 
reprogramming factors in the adult mouse heart will lead 
to the abnormal formation of cardiac myocytes in vivo 
and whether heart stem cells could be activated through 
a similar mechanism. Th   e fourth is whether iCMs from 
mouse heart disease models, such as models of 
hypertrophic cardiomyopathy and arrhythmias, will 
exhibit similar in vivo disease phenotypes.
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